Your session is about to expire
← Back to Search
Web-Based Program for Body Image After Head and Neck Cancer Treatment (BIHNC Trial)
N/A
Waitlist Available
Led By Bethany Rhoten, PhD
Research Sponsored by Bethany Rhoten
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 6 weeks
Awards & highlights
BIHNC Trial Summary
This trial will test a new web-based program to help people with head and neck cancer cope with their body image after treatment.
Who is the study for?
This trial is for individuals who finished head and neck cancer treatment between 3-24 months ago, are unhappy with their body's appearance or function post-treatment, and have significant body image concerns (BIS score > 10). It excludes those with cognitive impairments, inability to read computer text, non-English speakers, or anyone still in cancer treatment.Check my eligibility
What is being tested?
The study tests a six-week online program called BIHNC designed to help survivors of head and neck cancers. The program includes educational modules and personal reflection activities aimed at improving participants' body image.See study design
What are the potential side effects?
Since the interventions are psychoeducational rather than medical treatments, traditional side effects like you'd see with medication aren't expected. Participants may experience emotional discomfort while reflecting on their body image.
BIHNC Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ approximately 6 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 6 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Percentage of participants who complete program
Percentage of participants who will rate program as acceptable
Secondary outcome measures
Percentage of participants with improvement in body image indicators
BIHNC Trial Design
1Treatment groups
Experimental Treatment
Group I: Body Image after Head and Neck Cancer TreatmentExperimental Treatment2 Interventions
Find a Location
Who is running the clinical trial?
Bethany RhotenLead Sponsor
Bethany Rhoten, PhDPrincipal Investigator - Vanderbilt Medical Center
Vanderbilt-Ingram Cancer Center
1 Previous Clinical Trials
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently receiving treatment for head and neck cancer.You have significant concerns about your body image, as measured by a score higher than 10 on a specific scale.I am able to understand and make decisions about my health care.I am unhappy with my body's appearance or how it functions.I finished my head and neck cancer treatment between 3 to 24 months ago.
Research Study Groups:
This trial has the following groups:- Group 1: Body Image after Head and Neck Cancer Treatment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the total sample size for this clinical investigation?
"Affirmative. Clinicaltrials.gov indicates that this research effort, initially posted on April 5th 2021, is actively recruiting test subjects. In order to complete their findings, the team requires 20 participants from a single location."
Answered by AI
Are enrollments for this research experiment still being accepted?
"Per the information available on clinicaltrials.gov, enrollment is still open for this experiment. The trial was first published in April of 2021 and saw its last update on July 5th 2022."
Answered by AI
Share this study with friends
Copy Link
Messenger